Amgen (NASDAQ: AMGN) SVP receives RSU grant and 3,167 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amgen SVP & CCO Nancy A. Grygiel reported routine equity compensation activity. She received 485 shares of common stock as a grant, increasing her direct holdings to 7,494 shares, and was granted 3,167 non-qualified stock options at $329.59 per share, vesting in four annual installments starting on May 5, 2027.
The filing also shows 76 shares were withheld at $329.59 per share to cover tax obligations, leaving 7,418 directly held shares afterward. The stock grant consists of Restricted Stock Units that convert one-for-one into common shares as they vest, and the options are exercisable in equal parts through May 5, 2030 with an expiration on May 5, 2036. An indirect 401(k) holding of 106.1864 shares is also reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Grygiel Nancy A.
Role
SVP & CCO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 76 | $329.59 | $25K |
| Grant/Award | Nqso (Right to Buy) | 3,167 | $329.59 | $1.04M |
| Grant/Award | Common Stock | 485 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 7,418 shares (Direct);
Nqso (Right to Buy) — 6,334 shares (Direct);
Common Stock — 106.186 shares (Indirect, 401(k) Plan)
Footnotes (1)
- The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Key Figures
RSU share grant: 485 shares
Non-qualified stock options granted: 3,167 options at $329.59
Direct shares after grant: 7,494 shares
+5 more
8 metrics
RSU share grant
485 shares
Restricted Stock Units vesting in four annual installments from May 5, 2027
Non-qualified stock options granted
3,167 options at $329.59
Exercise price and size of new option grant on May 5, 2026
Direct shares after grant
7,494 shares
Total directly held common shares following the 485-share award
Direct shares after tax withholding
7,418 shares
Direct holdings after 76 shares were withheld for taxes
Tax withholding shares
76 shares at $329.59
Shares delivered to cover tax liabilities on May 6, 2026
Option vesting start date
May 5, 2027
First vesting date for non-qualified stock options
Option expiration date
May 5, 2036
Final expiration date for the non-qualified stock options
Indirect 401(k) holdings
106.1864 shares
Common stock held indirectly through a 401(k) plan
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), non-qualified stock options, Equity Incentive Plan, +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Equity"
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Dividend Equivalents financial
"DEs are credited to the reporting person's unvested Restricted Stock Units"
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
FAQ
What equity awards did Amgen (AMGN) grant to Nancy A. Grygiel in this Form 4?
Nancy A. Grygiel received a grant of 485 shares of Amgen common stock and 3,167 non-qualified stock options at $329.59 per share. Both awards vest in four equal annual installments beginning May 5, 2027, providing staged long-term equity compensation.
How do the Restricted Stock Units in the Amgen (AMGN) Form 4 vest and settle?
The Restricted Stock Units vest in four equal annual installments of 25% each starting May 5, 2027. Once vested, each RSU is paid out in one share of Amgen common stock, aligning compensation with future company performance over several years.
What are the terms of the non-qualified stock options reported for Amgen (AMGN)?
The Form 4 shows 3,167 non-qualified stock options with a $329.59 exercise price. These options vest and become exercisable in four equal annual installments beginning May 5, 2027, and expire on May 5, 2036, offering long-dated equity upside potential.
What indirect Amgen (AMGN) ownership is reported in Nancy Grygiel’s Form 4?
The filing reports 106.1864 Amgen common shares held indirectly through a 401(k) plan. This reflects retirement-plan holdings rather than directly held stock certificates, providing additional equity exposure alongside her directly owned shares and granted awards.